• Explore /
  • Poster
  • / LGR5 rs17109924 to predict chemoresistance to 5FU-based chemotherapy in adjuvant colon cancer.

LGR5 rs17109924 to predict chemoresistance to 5FU-based chemotherapy in adjuvant colon cancer.

Abstract Poster

Authors

null

Armin Gerger

Division of Clinical Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria

Armin Gerger , Sereina Herzog , Joanna Szkandera , Martin Pichler , Michael Stotz , Renate Schaberl-Moser , Hellmut Samonigg , Sigurd Lax , Gerhard Leitner , Wilfried Renner , Andrea Berghold , Heinz-Josef Lenz

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 3580)

DOI

10.1200/jco.2014.32.15_suppl.3580

Abstract #

3580

Poster Bd #

43

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Gastrointestinal Cancers Symposium

Prognostic value of tumor budding in patients with stage II and III colon cancer: A single-institution experience.

Prognostic value of tumor budding in patients with stage II and III colon cancer: A single-institution experience.

First Author: David Viñal

First Author: Martin D. Berger

First Author: Suganija Lakkunarajah

First Author: Rushabh Kiran Kothari